Health Platform Acquires Two Diagnostic Franchises to Expand Testing Portfolio
CRESSO Brands’ new acquisitions will help establish a large direct-access lab testing network in the U.S. to enhance wellness nationwide.
Read MorePosted by Andy Lundin | Aug 20, 2024 | Company News |
CRESSO Brands’ new acquisitions will help establish a large direct-access lab testing network in the U.S. to enhance wellness nationwide.
Read MorePosted by Andy Lundin | Aug 19, 2024 | Miscellaneous |
The lawsuit challenges the FDA rule that regulates LDTs as medical devices, arguing that the FDA lacks authority to impose such regulations.
Read MorePosted by Andy Lundin | Aug 19, 2024 | Sequencing Systems |
Ambry Genetics unveiled a new multiomic exome sequencing test that incorporates RNA analysis to enhance the detection of rare diseases.
Read MorePosted by Andy Lundin | Aug 16, 2024 | Prostate |
A newly discovered class of RNA molecules in extracellular vesicles could serve as biomarkers for non-invasive cancer diagnosis.
Read MorePosted by Andy Lundin | Aug 14, 2024 | Sequencing Systems |
GeneDx announced enhancements to its whole genome sequencing services, all aimed at accelerating diagnoses and improving health outcomes.
Read More